| Application no. and date | 17172800.9 (espacenet) (Federated) (European Patent Register), 20110822 | | Patent/reg. no. and date | DK/EP 3246044, 20201230 | | Publication date | 20171122 | | Priority no. and date | US 376160 P, 20100823 | | EP pub. no. and date |
EP 3246044 20171122 | | Effective date | | | Applicant/owner | Wyeth LLC, 66 Hudson Boulevard East
New York, NY 10001-2192, US | | Applicant ref. no. | V51253DK00 | | Inventor | KHANDKE, Lakshmi, Pfizer Global Research & Development
Five Giralda Farms
Madison, NJ New Jersey 07940, US,
ARUMUGHAM, Rasappa, Pfizer Global Research & Development
Five Giralda Farms
Madison, NJ New Jersey 07940, US,
LOUN, Bounthon, Pfizer Global Research & Development
575 Maryville Centre Drive
St Louis, MO Missouri 63141, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/095 (2006.01) , A61K 47/02 (2006.01) , A61K 47/34 (2017.01) , A61K 47/44 (2017.01) , G01N 33/569 (2006.01) | | Title | Stabile formuleringer af Neisseria-meningitidis-RLP2086-antigener | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
